Login about (844) 217-0978

Harpal Gill

In the United States, there are 52 individuals named Harpal Gill spread across 19 states, with the largest populations residing in California, Illinois, Washington. These Harpal Gill range in age from 48 to 87 years old. Some potential relatives include Gurmeet Singh, Judy Hill, Inderjit Kaur. You can reach Harpal Gill through various email addresses, including sunnyv***@hotmail.com, harpal.g***@aol.com, sim***@yahoo.com. The associated phone number is 703-577-6323, along with 6 other potential numbers in the area codes corresponding to 940, 908, 425. For a comprehensive view, you can access contact details, phone numbers, addresses, emails, social media profiles, arrest records, photos, videos, public records, business records, resumes, CVs, work history, and related names to ensure you have all the information you need.

Public information about Harpal Gill

Resumes

Resumes

Harpal Gill

Harpal Gill Photo 1

Harpal Gill

Harpal Gill Photo 2

Clinic Director

Harpal Gill Photo 3
Location:
Chicago, IL
Industry:
Health, Wellness And Fitness
Work:
Align Health and Wellness
Clinic Director
Education:
University of Toronto 1998 - 2003
Life University 1998 - 2003
Doctorates, Doctor of Chiropractic
Skills:
Back Pain, Chiropractic, Headaches, Neck Pain, Tmj Dysfunction, Pain Management, Tmj Treatment, Sciatica, Corporate Wellness, Chronic Pain, Wellness, Sports Injuries, Rehabilitation, Employee Wellness Programs, Auto Injuries, Low Back Pain, Myofascial Release, Personal Injury, Nutrition, Therapeutic Massage, Wellbeing, Migraine, Healthcare, Holistic Health, Smoking Cessation, Herniated Disc, Stress Management, Pregnancy, Stress, Injury Prevention, Public Speaking, Healing, Athletics
Languages:
English
Punjabi
Hindi

Harpal Singh Gill

Harpal Gill Photo 4

Coo At Fabrinet

Harpal Gill Photo 5
Position:
Ex. VP of Operations at Fabrinet, COO at Fabrinet
Location:
San Francisco Bay Area
Industry:
Medical Devices
Work:
Fabrinet
Ex. VP of Operations Fabrinet since May 2005
COO
Education:
Brunel University 1974 - 1978

Vice President Global Alliances, Vice President Connx Group

Harpal Gill Photo 6
Location:
Bellevue, WA
Industry:
Computer Software
Work:
Software Ag
Vice President Global Alliances, Vice President Connx Group Vision Critical 2011 - 2012
Senior Vice President Global Partner Program Connx Solutions 2011 - 2012
Senior Vice President Global Sales and Marketing Kogent Corporation Jun 2010 - Jun 2011
Executive Vice President Kogent Corporation Jun 2010 - Oct 2010
Vice President Business Development Merkle Oct 2009 - Jun 2010
Director of Business Development Sap Dec 2005 - Aug 2009
Global Alliances - Sales Manager Business Objects 2005 - Aug 2009
Global Alliances and Ondemand Sales Manager Crystal Decisions 2000 - Aug 2009
Sales Account Manager Business Objects Jun 1998 - Aug 2009
Global Alliances For Microsoft Business Objects Dec 2003 - Dec 2005
Senior Sales Account Manager Crystal Decisions 2001 - 2003
Sales Seagate Software 1998 - 2001
Sales Cis Client Information Systems 1995 - 1998
Sales
Skills:
Enterprise Software, Business Intelligence, Business Alliances, Strategy, Saas, Analytics, Solution Selling, Business Development, Go To Market Strategy, Business Objects, Professional Services, Software As A Service, Management, Cloud Computing, Software Industry, Integration, Sales, Partner Management, Crm, Strategic Partnerships, Lead Generation, Sales Process, Strategic Alliances, Demand Generation, Sales Enablement, Business Intelligence Tools, Leadership, Channel Partners, Dashboard, Cross Functional Team Leadership, Business Process, Marketing, Start Ups, Enterprise Architecture, Salesforce.com, Business Analytics, Complex Sales, Executive Management, Big Data, Consulting, Mobile Devices, Paas, Mergers and Acquisitions, E Commerce, Alliances, Software Sales, Business Management, Selling, Training, Multi Channel Marketing

Harpal Gill

Harpal Gill Photo 7
Location:
United States

Harpal Gill - Richmond, CA

Harpal Gill Photo 8
Work:
Alere Sep 2007 to 2000
NICU RN CCM Alta Bates Summit Medical Center Mar 2006 to 2000
NICU RN Children's Hospital Central California Jan 2004 to Jan 2006
NICU RN Management of Critical Ill Newborns Mar 2000 to Jan 2004 Doctor's Medical Center SanPablo and Pinole Jul 1997 to Jun 2001
RN
Education:
Contra Costa Community College Jun 1992 to May 1997
Associate in Liberal Arts
Background search with BeenVerified
Data provided by Veripages

Phones & Addresses

Name
Addresses
Phones
Harpal Gill
610-789-2707
Harpal K Gill
310-373-3903, 310-541-2741
Harpal S Gill
703-577-6323
Harpal K Gill
310-377-1614, 310-541-2741
Harpal K Gill
510-237-5231
Harpal Gill
940-595-2908
Harpal K Gill
734-595-8315
Harpal K Gill
734-595-8315

Business Records

Name / Title
Company / Classification
Phones & Addresses
Harpal S. Gill
HJD, INC
Harpal S. Gill
Principal
Harpal Singh Gill
Business Services at Non-Commercial Site
4486 W Escalon Ave, Fresno, CA 93722
Harpal Gill
COO
fabrinet (USA)
Business Services
4104 24Th St # 345, San Francisco, CA 94114
Harpal Gill
Executive Vice-President
Smb Business Intelligence Builders (America) Inc
Business Consulting Services
800 5 Ave, Seattle, WA 98104
866-797-8032
Harpal S Gill
Treasurer
H.S. PANNU ORCHARD, INC
23 Casa Way, Scotts Valley, CA 95066
Harpal Gill
Manager
HUE GUI Investments
Management Consulting Services
500 108Th Ave Ne, Bellevue, WA 98004
Harpal Gill
Manager
Hue Gui Investments
Investment Advisory Service · Administrative Management and General Management Consulting
500 108 Ave NE, Bellevue, WA 98004
425-990-6485
Harpal Gill
Chiropractor, ManagingOsteopathy, DO - CHIROPRACTOR
Mind Body Health Care LLC
Chiropractor's Office
125 Windsor Dr, Oak Brook, IL 60523
630-586-9299

Publications

Us Patents

Phenyloxadiazole Derivatives As Pgds Inhibitors

US Patent:
2012019, Jul 26, 2012
Filed:
Apr 4, 2012
Appl. No.:
13/439511
Inventors:
Christopher L. VANDEUSEN - East Windsor NJ, US
Franz J. WEIBERTH - Ringoes NJ, US
Harpal S. GILL - Lambertville NJ, US
George LEE - Somerville NJ, US
Andrea HILLEGASS - Nazareth PA, US
Assignee:
SANOFI - Paris
International Classification:
A61K 31/506
A61P 37/08
A61P 29/00
A61P 11/06
A61P 27/02
A61P 11/00
C07C 259/18
C07D 271/06
C07D 401/14
C07D 413/14
A61P 11/02
US Classification:
514256, 544333, 564229, 548131
Abstract:
This invention is directed to a compound of formula (I):wherein R1, R2 and R3 are as defined herein, a pharmaceutical composition comprising the compound, intermediates and processes for making said compounds, and the use of the compound to treat allergic and/or inflammatory disorders, particularly disorders such as allergic rhinitis, asthma, chronic obstructive pulmonary disease (COPD) and age-related macular degeneration (AMD).

Process For The Preparation Of Benzimidazol Thienylamine Compounds And Derivatives Thereof Useful As Sodium/Proton Exchanger Type 3 Inhibitors

US Patent:
2010017, Jul 8, 2010
Filed:
Dec 14, 2009
Appl. No.:
12/637096
Inventors:
Timothy Allen Ayers - Bridgewater NJ, US
Harpal S. Gill - Bridgewater NJ, US
Andrea Hillegass - Bridgewater NJ, US
Volker Derdau - Frankfurt am Main, DE
Assignee:
SANOFI-AVENTIS U.S. LLC - Bridgewater NJ
International Classification:
C07D 409/12
C07D 235/04
C07D 333/04
US Classification:
5462814, 5483047, 549 68
Abstract:
The present invention is an improved process for the preparation of a sodium/proton exchange inhibitor of sub-type 3 (NHE-3) useful in the treatment of sleep apnea and other related respiratory disorders. The improved synthesis of the NHE-3 inhibitor, more specifically a benzimidazol thienylamine, utilizes novel reagents and chemical intermediates and thereby results in an improved yield and purity of the final product with less reaction or synthetic steps required

Phenyloxadiazole Derivatives As Pgds Inhibitors

US Patent:
2017023, Aug 17, 2017
Filed:
Sep 7, 2016
Appl. No.:
15/258892
Inventors:
- Paris, FR
Franz J. WEIBERTH - Ringoes NJ, US
Harpal S. GILL - Lambertville NJ, US
George LEE - Somerville NJ, US
Andrea HILLEGASS - Nazareth PA, US
International Classification:
A61K 31/506
Abstract:
This invention is directed to a compound of formula (I):wherein R1, R2 and R3 are as defined herein, a pharmaceutical composition comprising the compound, intermediates and processes for making said compounds, and the use of the compound to treat allergic and/or inflammatory disorders, particularly disorders such as allergic rhinitis, asthma, chronic obstructive pulmonary disease (COPD) and age-related macular degeneration (AMD).

Novel Heterocyclic Amide Derivatives And Their Use As Dopamine D3 Receptor Ligands

US Patent:
2007014, Jun 21, 2007
Filed:
Dec 21, 2006
Appl. No.:
11/643594
Inventors:
James Hendrix - Hillsborough NJ, US
Joseph Strupczewski - Flemington NJ, US
Kenneth Bordeau - Kintnersville PA, US
Matthias Urmann - Eschborn, DE
Gregory Shutske - Pittstown NJ, US
John Jurcak - Bethlehem PA, US
Harpal Gill - West Chester OH, US
Franz Weiberth - Ringoes NJ, US
Thaddeus Nieduzak - Bridgewater NJ, US
Sharon Jackson - Whitehouse Station NJ, US
Paul Mueller - Hoboken NJ, US
Assignee:
Aventis Pharmaceuticals Inc. - Bridgewater NJ
International Classification:
A61K 31/498
A61K 31/46
C07D 451/02
C07D 487/04
US Classification:
514210160, 514304000, 514249000, 544349000, 546112000, 546124000
Abstract:
The invention relates to heterocyclic substituted amide derivatives that display selective binding to dopamine Dreceptors. In another aspect, the invention relates to a method for treating central nervous system disorders associated with the dopamine Dreceptor activity in a patient in need of such treatment comprising administering to the subject a therapeutically effective amount of said compounds for alleviation of such disorder. The central nervous system disorders that may be treated with these compounds include Psychotic Disorders, Substance Dependence, Substance Abuse, Dyskinetic Disorders (e.g. Parkinson's Disease, Parkinsonism, Neuroleptic-Induced Tardive Dyskinesia, Gilles de la Tourette Syndrome and Huntington's Disease), Dementia, Anxiety Disorders, Sleep Disorders, Circadian Rhythm Disorders and Mood Disorders. The subject invention is also directed towards processes for the preparation of the compounds described herein as well as methods for making and using the compounds as imaging agents for dopamine Dreceptors.

Novel Heterocyclic Amide Derivatives And Their Use As Dopamine D3 Receptor Ligands

US Patent:
2005010, May 19, 2005
Filed:
Oct 7, 2004
Appl. No.:
10/960399
Inventors:
James Hendrix - Hillsborough NJ, US
Kenneth Bordeau - Kintnersville PA, US
Matthias Urmann - Eschborn, DE
Gregory Shutske - Pittstown NJ, US
Horst Hemmerle - Noblesville IN, US
John Jurcak - Bethlehem PA, US
Harpal Gill - West Chester OH, US
Franz Weiberth - Ringoes NJ, US
Thaddeus Nieduzak - Bridgewater NJ, US
Sharon Jackson - Whitehouse NJ, US
Paul Mueller - Hoboken NJ, US
Assignee:
Aventis Pharmaceuticals Inc. - Bridgewater NJ
International Classification:
C07D471/02
C07D487/04
A61K031/503
A61K031/4745
US Classification:
514248000, 514300000, 544236000, 546117000
Abstract:
The invention relates to heterocyclic substituted amide derivatives that display selective binding to dopamine Dreceptors. In another aspect, the invention relates to a method for treating central nervous system disorders associated with the dopamine Dreceptor activity in a patient in need of such treatment comprising administering to the subject a therapeutically effective amount of said compounds for alleviation of such disorder. The central nervous system disorders that may be treated with these compounds include Psychotic Disorders, Substance Dependence, Substance Abuse, Dyskinetic Disorders (e.g. Parkinson's Disease, Parkinsonism, Neuroleptic-Induced Tardive Dyskinesia, Gilles de la Tourette Syndrome and Huntington's Disease), Dementia, Anxiety Disorders, Sleep Disorders, Circadian Rhythm Disorders and Mood Disorders. The subject invention is also directed towards processes for the preparation of the compounds described herein as well as methods for making and using the compounds as imaging agents for dopamine Dreceptors.

Phenyloxadiazole Derivatives As Pgds Inhibitors

US Patent:
2019000, Jan 3, 2019
Filed:
Feb 23, 2018
Appl. No.:
15/903337
Inventors:
- Paris, FR
Franz J. WEIBERTH - Ringoes NJ, US
Harpal S. GILL - Lambertville NJ, US
George LEE - Somerville NJ, US
Andrea HILLEGASS - Nazareth PA, US
International Classification:
A61K 31/506
C07D 217/06
C07D 271/06
C07D 413/14
Abstract:
This invention is directed to a compound of formula (I):wherein R1, R2 and R3 are as defined herein, a pharmaceutical composition comprising the compound, intermediates and processes for making said compounds, and the use of the compound to treat allergic and/or inflammatory disorders, particularly disorders such as allergic rhinitis, asthma, chronic obstructive pulmonary disease (COPD) and age-related macular degeneration (AMD).

Novel Heterocyclic Amide Derivatives And Their Use As Dopamine D3 Receptor Ligands

US Patent:
2004003, Feb 12, 2004
Filed:
Feb 19, 2002
Appl. No.:
10/078206
Inventors:
James Hendrix - Hillsborough NJ, US
Joseph Strupczewski - Flemington NJ, US
Kenneth Bordeau - Kintnersville PA, US
Matthias Urmann - Eschborn, DE
Gregory Shutske - Pittstown NJ, US
Horst Hemmerle - Indianapolis IN, US
John Jurcak - Bethlehem PA, US
Harpal Gill - West Chester OH, US
Franz Weiberth - Ringoes NJ, US
Thaddeus Nieduzak - Bridgewater NJ, US
Sharon Jackson - Whitehouse Station NJ, US
Paul Mueller - Hoboken NJ, US
International Classification:
C07F005/02
US Classification:
546/013000
Abstract:
The invention relates to heterocyclic substituted amide derivatives that display selective binding to dopamine Dreceptors. In another aspect, the invention relates to a method for treating central nervous system disorders associated with the dopamine Dreceptor activity in a patient in need of such treatment comprising administering to the subject a therapeutically effective amount of said compounds for alleviation of such disorder. The central nervous system disorders that may be treated with these compounds include Psychotic Disorders, Substance Dependence, Substance Abuse, Dyskinetic Disorders (e.g. Parkinson's Disease, Parkinsonism, Neuroleptic-Induced Tardive Dyskinesia, Gilles de la Tourette Syndrome and Huntington's Disease), Dementia, Anxiety Disorders, Sleep Disorders, Circadian Rhythm Disorders and Mood Disorders. The subject invention is also directed towards processes for the preparation of the compounds described herein as well as methods for making and using the compounds as imaging agents for dopamine Dreceptors.

Phenyloxadiazole Derivatives As Pgds Inhibitors

US Patent:
2019026, Aug 29, 2019
Filed:
Sep 20, 2018
Appl. No.:
16/137241
Inventors:
- Paris, FR
Franz J. WEIBERTH - Ringoes NJ, US
Harpal S. GILL - Lambertville NJ, US
George LEE - Somerville NJ, US
Andrea HILLEGASS - Nazareth PA, US
International Classification:
A61K 31/506
C07D 217/06
C07D 271/06
C07D 413/14
Abstract:
This invention is directed to a compound of formula (I):wherein R1, R2 and R3 are as defined herein, a pharmaceutical composition comprising the compound, intermediates and processes for making said compounds, and the use of the compound to treat allergic and/or inflammatory disorders, particularly disorders such as allergic rhinitis, asthma, chronic obstructive pulmonary disease (COPD) and age-related to macular degeneration (AMD).

FAQ: Learn more about Harpal Gill

What is Harpal Gill's email?

Harpal Gill has such email addresses: sunnyv***@hotmail.com, harpal.g***@aol.com, sim***@yahoo.com, hstillw***@sbcglobal.net, palai1***@sbcglobal.net, harpa***@yahoo.com. Note that the accuracy of these emails may vary and they are subject to privacy laws and restrictions.

What is Harpal Gill's telephone number?

Harpal Gill's known telephone numbers are: 703-577-6323, 940-595-2908, 908-268-5227, 425-922-2589, 918-458-0800, 610-266-6750. However, these numbers are subject to change and privacy restrictions.

How is Harpal Gill also known?

Harpal Gill is also known as: Harral S Gill. This name can be alias, nickname, or other name they have used.

Who is Harpal Gill related to?

Known relatives of Harpal Gill are: Jaswant Singh, Jaswinder Singh, Mandeep Singh, Darshan Ghuman, Manjinder Sagoo. This information is based on available public records.

What are Harpal Gill's alternative names?

Known alternative names for Harpal Gill are: Jaswant Singh, Jaswinder Singh, Mandeep Singh, Darshan Ghuman, Manjinder Sagoo. These can be aliases, maiden names, or nicknames.

What is Harpal Gill's current residential address?

Harpal Gill's current known residential address is: 795 Red Oak Ln, Geneva, OH 44041. Please note this is subject to privacy laws and may not be current.

What are the previous addresses of Harpal Gill?

Previous addresses associated with Harpal Gill include: 2605 Picadilly Ln, Denton, TX 76209; 105 Windy Way Dr, Madison, AL 35758; 1770 Bellevue Way Ne, Bellevue, WA 98004; 30098 Big Range Rd, Menifee, CA 92587; 5317 102Nd Pl Ne, Marysville, WA 98270. Remember that this information might not be complete or up-to-date.

Where does Harpal Gill live?

Geneva, OH is the place where Harpal Gill currently lives.

How old is Harpal Gill?

Harpal Gill is 63 years old.

What is Harpal Gill date of birth?

Harpal Gill was born on 1960.

People Directory:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z